Cinnamic Acid Derivatives as Anticancer Agents-A Review

被引:355
作者
De, P. [1 ,2 ]
Baltas, M. [1 ,2 ]
Bedos-Belval, F. [1 ,2 ]
机构
[1] Univ Toulouse, UPS, LSPCMIB, F-31062 Toulouse 9, France
[2] CNRS, LSPCMIB, F-31062 Toulouse 9, France
关键词
Anticancer agents; caffeic acid; cinnamic acid; cinnamide; cinnamoyl ester; cinnamic hydrazide; HISTONE DEACETYLASE INHIBITOR; PYRINDAMYCIN ALKYLATION SUBUNIT; ANTITUMOR ANTIBIOTIC CC-1065; HALF-MUSTARD DERIVATIVES; OSTEOSARCOMA MG-63 CELLS; PHENYL NITROGEN-MUSTARD; ABL TYROSINE KINASE; NF-KAPPA-B; CAFFEIC ACID; PHENETHYL ESTER;
D O I
10.2174/092986711795471347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cinnamic acid and its phenolic analogues are natural substances. Chemically, in cinnamic acids the 3-phenyl acrylic acid functionality offers three main reactive sites; substitution at the phenyl ring, addition at the alpha,beta-unsaturation and the reactions of the carboxylic acid functionality. Owing to these chemical aspects cinnamic acid derivatives received much attention in medicinal research as traditional as well as recent synthetic antitumor agents. We observed that in spite of their rich medicinal tradition, cinnamic acid derivatives and their anticancer potentials remained underutilized for several decades since the first published clinical use in 1905. In last two decades, there has been huge attention towards various cinnamoyl derivatives and their antitumor efficacy. This review provides a comprehensive and unprecedented literature compilation concerning the synthesis and biological evaluation of various cinnamoyl acids, esters, amides, hydrazides and related derivatives in anticancer research. We envisage that our effort in this review contributes a much needed and timely addition to the literature of medicinal research.
引用
收藏
页码:1672 / 1703
页数:32
相关论文
共 199 条
  • [1] A guide to 17β-hydroxysteroid dehydrogenases
    Adamski, J
    Jakob, FJ
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 171 (1-2) : 1 - 4
  • [2] Ahmed K., 2010, Int. Patent, Patent No. [WO 2010/052732 A1, 2010052732]
  • [3] Ahn BZ, 1996, CURR PHARM DESIGN, V2, P247
  • [4] Akao Y, 2003, BIOL PHARM BULL, V26, P1057, DOI 10.1248/bpb.26.1057
  • [5] The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity
    Alessi, F
    Quarta, S
    Savio, M
    Riva, F
    Rossi, L
    Stivala, LA
    Scovassi, AI
    Meijer, L
    Prosperi, E
    [J]. EXPERIMENTAL CELL RESEARCH, 1998, 245 (01) : 8 - 18
  • [6] An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO
  • [7] 2
  • [8] Caffeic Acid Phenethyl Ester, an Active Component of Honeybee Propolis Attenuates Osteoclastogenesis and Bone Resorption Via the Suppression of RANKL-Induced NF-κB and NFAT Activity
    Ang, Estabelle S. M.
    Pavlos, Nathan J.
    Chai, Lee Y.
    Qi, Ming
    Cheng, Tak S.
    Steer, James H.
    Joyce, David A.
    Zheng, Ming H.
    Xu, Jiake
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 221 (03) : 642 - 649
  • [9] A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity
    Aoyagi, Y
    Masuko, N
    Ohkubo, S
    Kitade, M
    Nagai, K
    Okazaki, S
    Wierzba, K
    Terada, T
    Sugimoto, Y
    Yamada, Y
    [J]. CANCER SCIENCE, 2005, 96 (09) : 614 - 619
  • [10] Development of farnesyl transferase inhibitors: A review
    Appels, NMGM
    Beijnen, JH
    Schellens, JHM
    [J]. ONCOLOGIST, 2005, 10 (08) : 565 - 578